Genetic Editing for Healthcare

Advances in Disease Management

Inbunden, Engelska, 2026

1 700 kr

Kommande

Beskrivning

This book presents a focused and timely exploration of genome editing and its transformativeimpact on modern medicine. Integrating interdisciplinary perspectives, the volume examines howemerging genetic technologies are reshaping the prevention, diagnosis, and treatment of complexdiseases.The book outlines the molecular foundations of key genome-editing tools, including CRISPRCas9,TALENs, and zinc-finger nucleases, explaining their mechanisms and expanding role inbiomedical research. It then moves to practical applications, highlighting case studies in areassuch as cancer treatment and precision medicine, demonstrating how gene-editing technologiesare improving patient outcomes.Beyond technical advances, the volume addresses critical ethical, legal, and regulatoryconsiderations, including biosafety, intellectual property, and human rights. By examining bothopportunities and challenges, it emphasizes the need for responsible and well-regulatedimplementation of genetic technologies.Bringing together current research and applied insights, this volume offers a clear and balancedperspective on the evolving role of genome editing in advancing healthcare worldwide.

Produktinformation

Utgivningsdatum:2026-08-18
Mått:152 x 229 x undefined mm
Format:Inbunden
Språk:Engelska
Antal sidor:250
Förlag:Apple Academic Press Inc.
ISBN:9781779643810

Utforska kategorier

Medicinsk genetik inom Medicin
Biomedicinsk teknik inom Medicin

Mer om författaren

Bhupinder Singh, PhD, is Professor at Sharda University, India, and Honorary Professor at theUniversity of South Wales, UK. He has over 16 years of experience and has authored numerouspublications and conference presentations across law and emerging technologies.Rishabha Malviya, PhD, is Associate Professor at Galgotias University, India, with expertise inpharmaceutics and drug delivery. He has published over 200 papers, holds multiple patents, andis listed among the world’s Top 2% Scientists per Stanford University.Sahil Lal, PhD, is Assistant Professor of Law at Galgotias University, India. His work focuses onintellectual property and emerging technologies, particularly artificial intelligence and innovationpolicy.Sathvik Belagodu Sridhar, PhD, is Associate Dean and Professor at RAK Medical and HealthSciences University, UAE, with over 25 years of experience in clinical pharmacy andpharmacovigilance research.

Recensioner i media

“A thorough, multidisciplinary examination of how genetic editing is revolutionizing medicine and providing fresh hope in the battle against complicated illnesses. . . . An extensive range of chapters on the ethical, legal, and societal consequences of gene editing, with a focus on human rights concerns and the legal frameworks that must adapt to incorporate the impact of gene editing. . . . An essential resource for healthcare experts, researchers, clinicians, and biomedical scientists in the future of healthcare and genetic technology.”—From the Foreword by Dr. Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

Innehållsförteckning

1. Gene Editing Governance and Genetic Engineering: A Framework for Regulating CRISPR Technology 2. Application and Challenges of the CRISPR/Cas9 System for Gene Editing 3. Impact of Genomics on Drug Discovery and Clinical Medicine on Public Healthcare: Fostering Disease Prevention and Enhancing Human Well-Being. 4. Challenges and Approaches to Human Genome Editing 5. Precision Medicine Through Gene Editing: Pharmacogenomics and the Future of Disease Management in Clinical Healthcare 6. Patenting the Genome: A Global Perspective of Intellectual Property Rights and Genetic Innovation 7. Biosafety Issues Relating to Genome Editing in Plants and its Impact on Human Health 8. Gene Editing and Human Rights: Legal Implications of CRISPR Technology 9. Genomic Innovations in Drug Discovery and Clinical Medicine 10. Impact of Genomics on Drug Discovery and Clinical Medicine: Fostering Gene Editing and Personalized Medicine, Bioinformatics and Artificial Intelligence